Filing Details

Accession Number:
0001415889-25-009127
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-27 19:14:25
Reporting Period:
2025-03-25
Filing Date:
2025-03-27
Accepted Time:
2025-03-27 19:14:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1192448 Glaukos Corp GKOS Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1920061 R. Alex Thurman C/O Glaukos Corporation
One Glaukos Way
Aliso Viejo CA 92656
Svp & Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-03-25 3,252 $107.61 56,543 No 4 F Direct
Common Stock Disposition 2025-03-25 1,592 $96.60 54,951 No 4 F Direct
Common Stock Disposition 2025-03-25 1,059 $106.56 53,892 No 4 S Direct
Common Stock Disposition 2025-03-25 430 $107.44 53,462 No 4 S Direct
Common Stock Disposition 2025-03-25 31 $108.14 53,431 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 24, 2022 and March 22, 2023.
  2. Includes 19,387 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  3. Consists of shares withheld by the Issuer with respect to tax withholding obligations of the Reporting Person upon vesting and delivery of shares of common stock underlying restricted stock units previously granted by the Issuer on March 14, 2024.
  4. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024.
  5. This transaction was executed in multiple trades at prices ranging from $105.98 to 106.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $107.03 to 107.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.